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The worldwide prevalence of highly resistant Gram-negative rods (HR-GNR) is increasing rapidly. Reliable
typing methods are needed to detect and control outbreaks and to monitor the effectiveness of infection control
programs in endemic situations. In this study, we investigated the performance of the DiversiLab typing
method in comparison with the amplified fragment length polymorphism (AFLP) typing method. Six hundred
fifty-three HR-GNR isolates, which were obtained during a 6-month prospective survey in 18 Dutch hospitals,
were typed by AFLP and DiversiLab. Subsequently, the sensitivity and specificity of DiversiLab were calculated,
using AFLP as the reference method. In addition, results were compared by means of epidemiological
linkage, and Cohen’s kappa for agreement was calculated. DiversiLab considered significantly more
isolates (275) to belong to a cluster than AFLP (198) (P < 0.001). In direct comparison, the sensitivity was
83.8%, and the specificity was 78.6%. When epidemiological linkage was included in the analysis, Diver-
siLab considered eight isolates as secondary cases, which were considered unique in AFLP. Only two
secondary cases, according to AFLP, were missed by DiversiLab. This results in a kappa for agreement of
0.985. In daily practice, a typing method has to be used in combination with epidemiological information.
When this was done, DiversiLab was shown to be a reliable method for the typing of HR-GNR. This, in
combination with the ease of use and the speed, makes DiversiLab an appropriate method for screening
in routine clinical practice. When a cluster is suspected and the consequences of these findings are
substantial, a confirmatory analysis should be performed.
Worldwide, the prevalence of highly resistant Gram-neg-
ative rods (HR-GNR) is increasing. In the annual report of
2008, the European Antimicrobial Resistance Surveillance
System concluded that resistance of Escherichia coli to four
antimicrobial classes, including broad-spectrum cephalospo-
rins, is already among the four most common resistance
patterns encountered in Europe (http://www.rivm.nl/earss
/result/Monitoring_reports/Annual_reports.jsp). In Kleb-
siella spp., even 14% of invasive isolates are resistant to
three classes of antimicrobial drugs, including broad-spec-
trum cephalosporins.
This increase can be caused by patients carrying resistant
pathogens on admission, by horizontal transfer between pa-
tients, by selection of resistance caused by antimicrobial use, by
transfer of resistance genes between microorganisms, or by
combination of two or more of these mechanisms (1, 6, 8).
In The Netherlands, national guidelines have been defined
that describe control measures to avoid the spread of resistant
bacteria between patients (5). In case of a suspected outbreak,
typing methods are essential to assess the presence and scale of
the outbreak. The most commonly used typing methods for
aerobic Gram-negative rods are amplified fragment length
polymorphism (AFLP) and pulsed-field gel electrophoresis
(PFGE). These methods are very reliable but also relatively
expensive and time-consuming, and they require a high level of
technical skill. Therefore, they cannot be used in most clinical
laboratories. We tested a commercially available typing
method, DiversiLab, on a well-defined collection of HR-GNR
from a recent study in Dutch hospitals (9). The objective of this
study was to determine the reliability of DiversiLab in com-
parison with the AFLP typing method for the typing of HR-
GNR in a hospital setting.
MATERIALS AND METHODS
Strain collection. The HR-GNR isolates were part of a collection from a
multicenter study performed in five university hospitals, eight teaching hospitals,
and five general hospitals during a 6-month study period in 2007. All isolated
strains, whether from clinical cultures or from screening cultures of clinical
patients, were included (9). In total, 653 HR-GNR isolates were available and
were included in this analysis. All isolates were sent to a central laboratory,
where they were stored, using Microbank vials, at 70°C until further testing.
Identification (GN) and antimicrobial susceptibility testing (AST-NO48) were
performed by using the VITEK2 system (bioMe´rieux, Marcy l’Etoile, France). If
the identification was considered “unacceptable” (probability below 85%) or if
the result differed from the identification from the participating hospital, API
20E/20NE (bioMe´rieux, Marcy l’Etoile, France) was performed as a confirma-
tion test, according to the manufacturer’s recommendations. The indole spot test
was used as a complementary test if recommended by the VITEK2 expert system.
If more than one HR-GNR was recovered from one patient, the second strain
was only included if this was another species or the same species with a different
susceptibility pattern. The criteria for HR-GNR used are described in the Dutch
national guideline for the control of highly resistant microorganisms (5). Table 1
shows a summary of these criteria.
AFLP typing method. For molecular typing, chromosomal DNA was isolated
using the easyMag system (bioMe´rieux, Marcy l’Etoile, France). Amplified frag-
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ment length polymorphism (AFLP) was performed as described by Savelkoul et
al. (7). Subsequent to restriction, ligation, and amplification, the DNA fragments
were separated on an ABI Prism 3130XL genetic analyzer (Applied Biosystems).
Genetic relatedness was determined on basis of both visual and computerized
interpretation of AFLP patterns.
DiversiLab typing method. The DiversiLab Microbial Typing System (bio-
Me´rieux, Marcy l’Etoile, France) is based on repetitive sequence-based PCR
(rep-PCR), which amplifies the regions between the noncoding repetitive se-
quences in bacterial genomes.
The DNA was isolated by the DiversiLab Mo Bio UltraClean microbial DNA
isolation kit, as recommended by the manufacturer. The DNA concentration was
measured and set between 25 ng/l and 30 ng/l. Subsequently, the DNA was
amplified using the DiversiLab fingerprinting kit for Escherichia spp., Klebsiella
spp., and other species, according to the manufacturer’s instructions. PCR was
performed using the following parameters: initial denaturation (94°C) for 2 min,
and then 35 cycles of 30 s of denaturation (94°C), 30 s of annealing (50 to 55°C
depending on the species), and 90 s of extension (70°C), followed by 3 min of
final extension (70°C) and ending at 4°C. The amplification products were sep-
arated with the Agilent B2100 bioanalyzer. Five microliters of DNA standard
markers (used for normalization of sample runs) and 1 l of the DNA product
were used. All data were entered in the DiversiLab software system.
Definition of epidemiological linkage. HR-GNR isolates recovered from a
specimen obtained from a patient more than 48 h after admission were classified
as hospital-associated HR-GNR; HR-GNR strains recovered less than 48 h after
admission were potential index cases. Nosocomial transmission was considered
present if genotypically related strains were detected in two or more patients who
had been in the same hospital ward within a maximum time window of 4 weeks
before cultures turned HR-GNR positive. The isolates from patients with hos-
pital-associated HR-GNR were considered secondary cases.
Statistical analysis. All data generated by AFLP were analyzed with Pearson’s
correlation coefficient and clustered by unweighted-pair group matrix analyses
using BioNumerics software, v5.10 (Applied-Maths, Sint-Martens-Latum,
Belgium). Clusters were formed according to the biological similarity of the
strains (7).
Results of the DiversiLab typing method were analyzed with the DiversiLab
software (version 3.4), which uses the Pearson correlation coefficient and the
unweighted-pair group method with arithmetic averages to determine distance
matrices and to create dendrograms. Reports were automatically generated.
Isolates with a similarity of at least 95% were considered a cluster.
We compared the results of both typing methods in two distinctive ways. First,
we compared the typing methods directly, with AFLP as the gold standard. If
DiversiLab was in agreement with the gold standard and considered an isolate to
be part of a cluster that was also found using AFLP, the result was scored as true
positive. If DiversiLab and AFLP both considered an isolate to be unique, the
result was scored as true negative. If the gold standard considered an isolate to
be unique and DiversiLab considered it as part of a cluster, the result was scored
as false positive. On the contrary, if the gold standard considered an isolate to be
part of a cluster and DiversiLab did not or clustered it with other isolates not
belonging to the AFLP-cluster, the result was considered false negative. Sensi-
tivity was calculated by dividing the number of true positives by the sum of true
positives and false negatives. Specificity was calculated by dividing the number of
true negatives by the sum of true negatives and false positives. This calculation
was done for each participating hospital separately.
Second, we included epidemiological linkage in the analysis and compared
DiversiLab and AFLP with each other. This was done by calculation of the
transmission index (TI). The TI was defined as the number of patients with a
nosocomial transmission (secondary cases) divided by the number of patients
with an HR-GNR not acquired by nosocomial transmission (potential index
cases) (9). This was calculated for both AFLP and DiversiLab and for each
hospital separately. Also, a Cohen’s kappa for agreement was calculated by
dividing the number of strains where AFLP and DiversiLab were in agreement
by the total number of strains. This was done for each hospital separately.
RESULTS
Strain collection. Of a total of 892 HR-GNR included in the
initial study (9), 653 isolates (559 Enterobacteriaceae and 94
nonfermentative Gram-negative rods) were available for fur-
ther typing. As shown in Table 2, E. coli was the most prevalent
species included in this study (296 isolates [53.0%]). Of the
TABLE 1. Definition of HR-GNR
Species
Type of resistance toa:
ESBL CTZ QUI AMG CAR PIP COT
Enterobacteriaceae
Escherichia coli A B B A
Klebsiella A B B A
Other Enterobacteriaceae A B B A B
Nonfermenters
Acinetobacter B B B A
Stenotrophomonas maltophilia A
Other nonfermenters C C C C C C
a ESBL, extended-spectrum -lactamase production; CTZ, ceftazidime; CAR,
carbapenems; QUI, fluoroquinolones; AMG, aminoglycosides; PIP, piperacillin;
COT, co-trimoxazole. In resistance type A, resistance against an antibacterial
agent of the carbapenem group, and/or the presence of ESBL production, and/or
resistance against cotrimoxazole is sufficient to define the microorganism as
highly resistant. In resistance type B, resistance against antibacterial agents from
at least two of the indicated groups or the specified antibacterial agent is re-
quired to define the microorganism as highly resistant. In resistance type C,
resistance against antibacterial agents from at least three of the indicated groups
or specified antibacterial agent is required to define the microorganism as highly
resistant.
TABLE 2. Distribution of species
Species No. ofisolates
AFLP DiversiLab
No. (%) in cluster No. (%) ofsecondary cases No. (%) in cluster
No. (%) of
secondary cases
Enterobacteriaceaea
Citrobacter 28 0 (0.0) 0 (0.0) 6 (21.4) 0 (0.0)
Enterobacter 68 24 (37.5) 8 (33.3) 41 (59.4) 11 (26.8)
Escherichia coli 296 119 (40.2) 11 (9.2) 158 (53.4) 13 (8.2)
Klebsiella 110 34 (30.9) 13 (38.2) 40 (36.4) 13 (32.5)
Proteus 37 11 (29.7) 2 (18.2) 14 (37.8) 2 (14.3)
Nonfermentative GNRb
Acinetobacter 15 2 (13.3) 0 (0.0) 0 (0.0) 0 (0.0)
Chryseobacterium 8 2 (25.0) 1 (50.0) 4 (50.0) 1 (25.0)
Pseudomonas 38 6 (15.8) 0 (0.0) 9 (23.7) 1 (11.1)
Stenotrophomonas 26 0 (0.0) 0 (0.0) 3 (11.5) 1 (33.3)
a Of 20 other Enterobacteriaceae, no clusters were found. This group consists of nine Morganella morganii isolates, two Providencia isolates, two Salmonella isolates,
five Serratia isolates, and two Shigella isolates.
b Of seven other nonfermentative GNR, no clusters were found. This group consists of five Achromobacter isolates, one Ochrobactrum anthropi isolate, and one
Sphingomonas paucimobilis isolate.
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nonfermentative Gram-negative rods, Pseudomonas spp. were
the most prevalent (38 isolates [40.4%]).
Direct comparison of AFLP and DiversiLab. Using AFLP,
188 Enterobacteriaceae and 10 nonfermentative Gram-negative
rods were considered to belong to a cluster. In total, 71 clusters
were found, with a median cluster size of 2 isolates. The largest
cluster contained 11 isolates. Using DiversiLab, 259 Enterobac-
teriaceae and 16 nonfermentative Gram-negative rods be-
longed to a cluster. These isolates are distributed over 91
clusters. The median cluster size was 2, and the largest cluster
contained 13 isolates. The number of isolates belonging to a
cluster was significantly higher for Enterobacteriaceae in Diver-
siLab compared with AFLP (P  0.001). Using AFLP, the
isolates of five hospitals were all unique. The other hospitals
revealed 1 to 11 clusters. Using DiversiLab, the same five
hospitals revealed no clusters. The other hospitals revealed
between 1 and 16 clusters. In Table 3, the number of clusters
and the number of isolates in the clusters of each hospital are
shown. Also, the sensitivity and specificity, calculated by direct
comparison of AFLP and DiversiLab, are calculated. The over-
all sensitivity was 83.8% and ranged from 57.1% to 100.0% in
the various hospitals. The overall specificity was 78.6%, with a
range from 66.7% to 100%.
Comparison of transmission indices. In Table 4, the results
with the addition of epidemiological linkage are shown. The
numbers of primary and secondary cases per hospital are given,
as well as the transmission index and the kappa value within
each hospital.
The TI values in 14 out of 18 hospitals were identical for
AFLP and DiversiLab. AFLP and DiversiLab were not in
agreement for the epidemiological linkage of 10 isolates com-
ing from four hospitals: 8 isolates were considered primary
cases by AFLP and secondary cases by DiversiLab, and 2
isolates were considered primary cases in DiversiLab and sec-
ondary cases by AFLP. This results in a kappa of 0.985 (range,
0.884 to 1.000).
Organisms within a cluster did not always exhibit the same
resistance phenotype, even if transmission was suspected.
However, for all but 1 of the 10 isolates where AFLP and
DiversiLab were not in agreement for the epidemiological
linkage, the resistance patterns of the primary and secondary
cases were identical.
DISCUSSION
In this study, we evaluated the performance of the Diversi-
Lab typing method. This was done by using a well-described
collection of HR-GNR. Our evaluation showed that Diversi-
Lab considered significantly more isolates to be part of a clus-
ter compared to AFLP (P 0.001). In a direct comparison, the
sensitivity was 83.8%, and the specificity was 78.6%. However,
when epidemiological linkage was included in the analysis, the
performance of DiversiLab was comparable to AFLP. In other
words, the interrelationships between the isolates in the clus-
ters found with DiversiLab were comparable to the interrela-
tionships between the isolates in the clusters found with AFLP.
In 14 hospitals, the results were in full agreement. As a result,
the overall kappa was very high (0.985), which indicated a good
concordance between the two tests.
A number of other studies evaluating DiversiLab have been
published (2–4). Most evaluate DiversiLab for only one spe-
cies, and a number of reference methods have been used. Fluit
et al. evaluated DiversiLab with a number of well-typed species
and showed that DiversiLab was a useful tool to help identify
hospital outbreaks of Acinetobacter spp., Stenotrophomonas
maltophilia, Enterobacter cloacae, Klebsiella spp., and E. coli,
but was considered inadequate for Pseudomonas aeruginosa
(3). Our results are in line with these findings, except for the
TABLE 3. Direct comparison of AFLP and DiversiLab
Hospital
AFLP DiversiLab
Sensitivity (%) Specificity (%)No. of
clusters
No. (%) of isolates
in clusters
No. of
clusters
No. (%) of
isolates in clusters
1 8 27 (31.0) 13 44 (50.6) 100.0 71.7
2 2 6 (16.2) 4 11 (29.7) 100.0 86.7
3 7 19 (47.5) 8 21 (52.5) 94.7 85.7
4 0 0 (0.0) 0 0 (0.0) NAa 100.0
5 6 17 (39.5) 7 26 (60.5) 94.7 66.7
6 2 4 (33.3) 2 4 (33.3) 100.0 100.0
7 8 20 (31.3) 8 25 (39.1) 75.0 79.6
8 0 0 (0.0) 0 0 (0.0) NA 100.0
9 0 0 (0.0) 0 0 (0.0) NA 100.0
10 0 0 (0.0) 0 0 (0.0) NA 100.0
11 0 0 (0.0) 0 0 (0.0) NA 100.0
12 7 18 (43.9) 7 20 (48.8) 83.0 82.6
13 2 7 (23.3) 2 7 (23.3) 57.1 87.0
14 1 2 (66.7) 1 2 (66.7) 100.0 100.0
15 2 4 (30.8) 2 4 (30.8) 100.0 100.0
16 6 12 (23.5) 10 21 (41.2) 91.7 76.9
17 11 38 (31.4) 16 57 (48.3) 76.9 69.6
18 9 26 (28.6) 11 33 (36.3) 61.5 76.9
Overall 71 201 (30.7) 91 276 (42.1) 83.8 78.6
a NA, not applicable.
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conclusions regarding P. aeruginosa. However, another recent
study showed a good performance of DiversiLab with P. aerugi-
nosa in comparison with PFGE (2). Our results were also in
line with a study by Grisold and colleagues (4), who showed
concordant results for identification of outbreak and non-out-
break-related Acinetobacter baumannii and extended-spectrum
-lactamase (ESBL)-producing Klebsiella pneumoniae strains
for PFGE and DiversiLab.
Our study is, according to us, unique because we included all
resistant Gram-negative species found in several hospitals in a
specific period. In addition, our analysis includes epidemiolog-
ical linkage, which is mandatory to evaluate the effect of using
the typing method in daily practice. The main limitation of our
study was that we only included highly resistant Gram-negative
rods, whereas in daily practice, the method will also be used for
outbreaks of highly resistant Gram-positive bacteria.
In conclusion, our study shows that the sensitivity and spec-
ificity of DiversiLab are lower than those of AFLP. However,
when epidemiological linkage is included in the analysis, the
performance is very good (kappa of 0.985), leading to similar
conclusions about horizontal spread of HR-GNR. The good
performance, in combination with the ease of use and the
speed, makes DiversiLab an appropriate screening method in
routine clinical practice. However, when the screening indi-
cates a severe problem that would justify extensive control
measures, a more discriminatory method (e.g., AFLP) should
be used to determine the true extent of the outbreak.
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